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2 
Abstract  
 
A critical step in gene expression is the faithful translation of protein from messenger 
RNA. This process relies on the attachment of specifically paired amino acids to their respective 
tRNAs by aminoacyl-tRNA synthetases (aaRSs). To ensure high accuracy of tRNA 
aminoacylation, aaRSs rely on maintaining high substrate specificity and editing activity. While 
editing significantly decreases the frequency of errors during aa-tRNA synthesis in vitro, many 
details of the reaction remain unknown. Eukaryotic organisms contain two distinct phenylalanyl-
tRNA synthetases (PheRS), a cytoplasmic (cytoPheRS) and a mitochondrial form (mitotPheRS). 
Saccharomyces cerevisiae cytoPheRS has lost some amino acid specificity but maintains an 
editing acitivity, while the mitoPheRS maintains amino acid specificity but has lost editing 
activity. To investigate the impact of editing activity on the cell, S. cerevisiae cytoPheRS was 
engineered to have a high level of amino acid specifity with and without editing activity. To do 
this the wild-type FRS2 gene, which encodes the cytoPheRS α-subunit and contains the active 
site, was cloned onto a centromeric plasmid and used to complement a heterozygous FRS2 
deletion (FRS2/frs2). The FRS2 wild-type gene product was found to be functional in vivo. The 
FRS2 specificity mutant (frs2-1) was also cloned and determined to be functional in vivo as well. 
The functional frs2-1 strain will next be used to complement an editing defective strain (frs1-1) 
which shows an amino acid dependent growth defect. This work will help clarify the impact of 
amino acid specificity and post-transfer editing on cellular physiology. 
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Introduction 
The process by which information from a gene is used to synthesize a functional gene 
product and subsequently the macromolecular machinery necessary for life is termed gene 
expression. One of the critical steps in gene expression is the faithful translation of protein from 
messenger RNA. The fidelity of translation is determined by two events: the synthesis of cognate 
amino acid:tRNA pairs by aminoacyl-tRNA synthetases (aaRSs) and accurate selection of 
aminoacyl-tRNAs (aa-tRNAs) by the ribosome. The amino acid first binds to the active site of 
the aaRS and is activated by ATP, leading to the formation of an aminoacyl-adenylate and the 
release of an inorganic pyrophosphate (Figure 1). The amino acid is then transferred to the 
terminal adenosine of the tRNA, leading to the formation of the aa-tRNA and the release of 
AMP. These aa-tRNAs, once formed by aaRSs, are delivered to the ribosome by EF-Tu for 
protein synthesis.  EF-Tu, or elongation factor thermo unstable, delivers the aminoacly-tRNA 
(aa-tRNA) to the A site of the ribosome and, if the pairing between the tRNA and the mRNA is 
correct, the amino acid is attached to the growing polypeptide (protein) chain.  
 
Figure 1. Synthesis of aminoacyl-tRNA by aminoacyl-tRNA synthetases. Two-step reaction of 
aminoacyl-tRNA synthesis by aminoacyl-tRNA synthetases. An aminoacyl-adenylate is first formed 
by the activation of the amino acid with ATP. The aminoacyl group is then transferred to the 3’ end 
of the tRNA and the aminoacyl-tRNA is released. 
 
Errors in aminoacylation may result in the incorporation of the incorrect amino acid 
during protein synthesis. To ensure a high accuracy of aminoacylation, aaRSs rely on 
maintaining high substrate specificity. Amino acid specificity is achieved by aaRSs through the 
preferential binding of cognate amino acids over non-cognate amino acids as well as the editing 
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of non-cognate amino acids (Ibba and Söll, 2000). Most eukaryotic organisms contain two 
distinct aaRS genes, one that encodes for an aaRS in the cytoplasm and the other in the 
mitochondria (Figure 2). Saccharomyces cerevisiae cytoplasmic phenylalanyl-tRNA synthetase 
(cytoPheRS) has lost some amino acid specificity but maintains an editing acitivity, while the 
mitochondrial phenylalanyl-tRNA synthetase (mitoPheRS) maintains amino acid specificity but 
has lost editing activity (Roy et al., 2005). 
 
Figure 2. Sub-cellular targeting of PheRS. Mitochondrial and cytosolic forms of PheRS are  
both encoded in the nucleus by separate genes. After exiting the nucleus mtPheRS is imported  
into the mitochondria. 
 
CytoPheRS is a multidomain (αβ)2 heterotetrameric enzyme made of two αβ dimers. The  
α-subunit contains the active site of the enzyme where the incoming amino acid is activated by 
ATP to form an aminoacyl-adenylate followed by attachment to the tRNA 3’-end, while the β-
subunit contains an editing domain. Both of these functions, the amino acid specificity and the 
editing activity, function to maintain quality control of cytoplasmic translation. 
Mutations in editing have been shown to adversely affect cell growth and viability in 
vivo, particularly under cell stress (Nangle et al., 2002). Slight perturbations in editing have been 
shown to result in severe phenotypic effects and in the absence of editing, misactivation by 
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aaRSs can produce levels of misincorporation that eventually increase the DNA mutation rate 
(Bacher and Schimmel, 2007). However, editing is not universally conserved in aaRSs. For 
instance, cytoplasmic proline-tRNA synthetase (ProRSs) from archaea and higher eukaryotes 
lack a posttransfer editing domain, while some other eukaryotic species have obsolete editing 
domains (Stern et al., 2007). Eukaryotic mitochondrial phenylalanyl-tRNA synthetase (PheRS) 
and human mitochondrial leucine-tRNA synthetase (LeuRS) have completely lost their editing 
activity and in yeast mitoLeuRS editing is unnecessary; instead, these aaRSs rely solely on a 
high level of amino acid specificity (Roy et al., 2005; Karkhanis et al., 2006). This loss of 
editing activity is restricted to the organellar forms of these synthetases, and the continued need 
for editing by their cytosolic complements suggests that there are different controls placed on the 
fidelity of protein synthesis in various subcellular compartments (Yao et al., 2008). While 
editing significantly decreases the frequency of errors during aa-tRNA synthesis in vitro, many 
details of the reaction remain unknown.   
To investigate the impact of editing activity on the cell, Saccharomyces cerevisiae 
cytoplasmic phenylalanyl-tRNA synthetase (cytoPheRS) was engineered to enhance substrate 
specificity as a means to make the active site more specific for Phe. To do this the wild-type 
FRS2 gene, which encodes the cytoPheRS α-subunit and is the active site (Figure 3), was cloned 
onto a centromeric plasmid and used to complement a heterozygous FRS2 deletion (frs2). The 
FRS2 wild-type gene product was found to be functional in vivo. The FRS2 specificity mutant 
(frs2-1) was also cloned and the gene product was determined to be functional in vivo as well. 
The functional  frs2-1 strain will next be used to complement an editing defective strain which 
shows an amino acid dependent growth defect. This work will help clarify the impact of amino 
acid selectivity and post-transfer editing on cellular physiology.   
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T415G 
Figure 3. PheRS active site. (A) T. thermophius PheRS with Phe at the active site with cytoPheRS numbering. (B) Specificity 
determinants highlighted in a PheRS sequence alignment (cytoPheRS numbers) (adapted from Reynolds et al., 2010). 
 
Materials and Methods 
Polymerase chain reaction was used to amplify wild-type FRS2 (encoding the cytoPheRS 
-subunit) gene sequence and regulatory regions from S. cerevisiae BY4743. The gel-purified 
2700 bp PCR product was then cloned into the centromeric plasmid, pFL36, using In-Fusion 
cloning (Zhu et al., 2007). The resulting plasmid (pFL36-FRS2) was sequenced to confirm 
proper cloning and lack of mutations.  The pFL36-FRS2 was transformed into the heterozygous 
FRS2 deletion (frs2Δ) S. cerevisiae strain BY4743 YFL022C (MATa/MATα, his3Δ1/his3Δ1, 
leu2Δ0/ leu2Δ0, lys2Δ0/LYS2, MET15/met15Δ0, ura3Δ0/ura3Δ0, FRS2/frs2) (ATCC). The 
resulting strain was sporulated on sporulation medium (1 % CH3COOK, 0.1 % yeast extract, 
0.05 % glucose) and spores dissected onto yeast extract/peptone/dextrose (YPD).  The dissected 
spores were grown at 37 C and replicated onto YPD with 200 g/mL Geneticin (G418), to 
select for spores containing the frs2 knock-out, and complete supplement media minus leucine 
(CSM –Leu; Sunrise Science Products), to select for spores containing the pFL36-FRS2 plasmid, 
and grown for 48 hours at 37 C.  
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In vivo site directed mutagenesis was performed with pFL36-FRS2 to introduce the 
G458A mutation (frs2-1) and the resulting plasmid (pFL36-frs2-1) was sequenced to confirm the 
G458A mutation.  The purified pFL36-frs2-1 plasmid was then transformed into the 
heterozygous FRS2 deletion (frs2Δ) S. cerevisiae strain BY4743 YFL022C and the resulting 
strain was sporulated and spores dissected onto YPD as above. The dissected spores were grown 
for 48 hours at 37 C, replicated onto G418 to select for spores containing the frs2∆ and CSM 
minus leucine to select for spores containing the pFL36-FRS2 plasmid.  Replica plates were 
grown for 48 hours at 37 C. 
The cytoPheRS α and β subunits, encoded by the FRS2 and FRS1 genes, respectively, 
were expressed in tandem from pQE31-FRS-sc (producing His6-tagged WT cytoPheRS) in E. 
coli (Roy et al., 2005). The T415G and G458A mutations were introduced into the cytoPheRS -
subunit using Quikchange site-directed mutagenesis.  His6-tagged proteins were purified on 
nickel-nitrilotriacetic acid-agarose by standard procedures.  
 
Results 
 CytoPheRS G458A shows increased amino acid specificity and decreased catalytic 
efficiency. However, the double mutant T415G/G458A showed less than 5% activity.  
 
 
Table 1. CytoPheRS has low amino acid specificity. Steady state kinetic constants of cytosolic wild type  
and binding site mutant PheRSs for ATP-[32P]PPi exchange (performed by NMR with the assistance of SR).  
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 Wild-type cytoPheRS FRS2, pFL36-FRS2, shows growth on YPD and G418 
demonstrating that pFL36-FRS2 is able to complement the frs2-1 and support growth (Figure 
4). FRS2 is an essential gene necessary for cell growth and survival. Growth of all four of the 
wild-type cytoPheRS FRS2, pFL36-FRS2, spores on YPD indicates that each spore had a 
functional FRS2 gene. In these spores, the functional FRS2 gene could be present as solely wild-
type FRS2 gene on the chromosome or as wild-type FRS2 on the chromosome in combination 
with the plasmid, pFL36-FRS2, or as solely on the plasmid, pFL36-FRS2, in combination with 
the knock-out frs2Δ that contains a kanMX cassette.  
To select for spores that contained the knock-out frs2Δ and the plasmid, pFL36-FRS2, the 
tetrads were replica-plated onto G418 plates. G418 is an antibiotic whose resistance is conferred 
by kanMX, which was put in place of the wild-type FRS2 gene in the knock-out. As a 
centromeric plasmid pFL36 replicates similar to natural chromosomes, meaning that each tetrad 
should have received a copy of the pFL36-FRS2 plasmid. However, as the S. cerevisiae BY4743 
YFL022C strain was heterozygous for the FRS2 gene, only those tetrads that received the 
plasmid and had the knock-out with the kanMX cassette should have been able to grow on G418.   
Growth of mutant G458A cytoPheRS frs2-1, pFL36-frs2-1, on YPD and G418 shows that 
pFL36-frs2-1 is also able to complement frs2-1 and support growth. 
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Figure 4. CytoPheRS complementation.  Dissection of tetrads from S. cerevisiae FRS2/frs2  
complemented with (A) pFL36-FRS2, (B) pFL36-frs2-1 and (C) pFL36 onto YPD and replica plated  
onto G418.  
 
Discussion 
 S. cerevisiae cytoplasmic phenylalanyl-tRNA synthetase (cytoPheRS) has been shown to 
have low amino acid specificity, as approximately one Tyr is activated for every ~480 Phe 
activated (Table 1). However, cytoPheRS does have an editing activity which compensates for 
this lack of selectivity. Changing the selectivity of the active site by changing the Glycine 
residue at position 458 into an Alanine residue nevertheless enhances the selectivity of the α-
subunit of cytoPheRS so that only one Tyr is activated for every ~10000 Phe activated (Table 1). 
Based on the steady-state kinetic constants of cytosolic PheRSs for ATP-[32P]PPi exchange, the 
catalytic efficiency of the G458A cytoPheRS mutant was so low that in vivo functionality was 
uncertain.  However, growth of both the wild-type pFL36-FRS2 and the mutant pFL36-frs2-1 
tetrads show that specificity of the active site can be enhanced and still functional in vivo. Other 
aaRS mutants (T415G/G458A) showed less than 5% activity, making the cytoPheRS G458A 
mutant the best system to study the need for specificity versus editing activity.  
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 The need for specificity versus editing activity will be determined by complementing an 
editing deficient strain of the cytoPheRS with pFL36-frs2-1. The editing deficient strain shows 
no growth phenotype on rich media where the ratio between Phe and Tyr is 4:1 (Reynolds et al., 
2010). However, the editing deficient strain shows a growth phenotype on minimal media where 
the Phe to Tyr ratio is only 1:1.1 (Reynolds & M Ibba, unpublished data). Using the pFL36-frs2-
1 plasmid, the editing deficient strain will be complemented and grown on minimal media to see 
if the wild-type growth phenotype can be recovered.  However, as the G458A mutation result in 
a KM defect for Phe and thus is sensitive to amino acid concentrations, growth of the strain 
carrying the pFL36-frs2-1 in minimal media, where the free phenylalanine concentration is 
reduced is an important test of function. Preliminary results suggest that G458A has a slow 
growth phenotype on minimal media (data not shown).  These experiments provide the 
groundwork for the further clarification of the impact and importance of amino acid specificity 
and post-transfer editing by aaRSs on cellular physiology.  
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Protein synthesis has an overall error rate of approximately 10−4 for each mRNA codon 
translated. The fidelity of translation is mainly determined by two events: synthesis of cognate 
amino acid:tRNA pairs by aminoacyl-tRNA synthetases (aaRSs) and accurate selection of 
aminoacyl-tRNAs (aa-tRNAs) by the ribosome. To ensure faithful aa-tRNA synthesis, many 
aaRSs employ a proofreading (“editing”) activity, such as phenylalanyl-tRNA synthetases 
(PheRS) that hydrolyze mischarged Tyr-tRNAPhe. Eukaryotes maintain two distinct PheRS 
enzymes, a cytoplasmic (ctPheRS) and an organellar form. CtPheRS is similar to bacterial 
enzymes in that it consists of a heterotetramer in which the α-subunits contain the active site and 
the β-subunits harbor the editing site. In contrast, mitochondrial PheRS (mtPheRS) is an α-
subunit monomer that does not edit Tyr- tRNAPhe, and a comparable transacting activity does not 
exist in organelles. Although mtPheRS does not edit, it is extremely specific as only one Tyr- 
tRNAPhe is synthesized for every ~7; 300 Phe- tRNAPhe, compatible with an error rate in 
translation of ~10−4. When the error rate of mtPheRS was increased 17-fold, the corresponding 
strain could not grow on respiratory media and the mitochondrial genome was rapidly lost. In 
contrast, error-prone mtPheRS, editing-deficient ctPheRS, and their wildtype counterparts all 
supported cytoplasmic protein synthesis and cell growth. These striking differences reveal 
unexpectedly divergent requirements for quality control in different cell compartments and 
suggest that the limits of translational accuracy may be largely determined by cellular 
physiology.   
 
aminoacyl-tRNA synthetase - protein synthesis - tRNA 
 
 
Introduction 
Typical error rates for individual steps in gene maintenance and expression range from 
10−8 for DNA replication (1) to 10−5 for mRNA transcription (2) and 10−4 for mRNA translation 
(3). These low error rates are achieved through high substrate specificity augmented by 
monitoring and proofreading of erroneous product synthesis, ensuring a high level of quality 
control. Whereas each cellular quality control mechanism has optimized its own level of 
specificity, translation as a whole limits misincorporation of the incorrect amino acid to one per 
10,000 mRNA codons (3, 4). The fidelity of translation is determined by multiple events 
including synthesis of cognate amino acid:tRNA pairs by aminoacyl-tRNA synthetases (aaRSs), 
binding and delivery of aminoacyl-tRNAs (aa-tRNAs) to the ribosome by elongation factors, and 
accurate selection of aa-tRNAs by the ribosome (5, 6). Despite the widely held notion that limits 
on quality control, and tolerable error rates, are a fundamental aspect of all cells, recent studies 
suggest that wide disparities exist between different cell types particularly during translation. For 
example, partial ablation of aaRS proofreading in mice had no discernible effect on early growth 
and development but specifically impacted neuronal cells leading to ataxia and 
neurodegeneration in older animals (7).   
During translation of the genetic code, aaRSs provide a critical step in quality control by 
preferentially selecting cognate pairs of tRNAs and amino acids while discriminating against 
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near- and noncognate molecules. The unique combinations of sequences and structures found in 
particular tRNAs allow cognate molecules to be specifically selected out of the large cellular 
pool of similar molecules without recourse to proofreading (5, 8). Amino acids, by contrast, 
present a much more challenging problem for their cognate aaRS. The 20 naturally occurring 
amino acids do not display a sufficiently diverse range of functional groups that would allow 
aaRSs to discriminate between them with a level of accuracy consistent with the error rate 
assigned to translation (9). To prevent degeneracy of the genetic code by the infiltration of near-
cognate amino acids, a number of proofreading activities are employed by aaRSs. These editing 
activities can occur through the hydrolysis of misactivated aminoacyladenylates (pretransfer 
editing) and/or through the hydrolysis of mischarged aa-tRNAs (posttransfer editing) (10). For 
example, the editing activities of phenylalanyl-tRNA synthetase (PheRS) prevent the delivery of 
Tyr- tRNAPhe to the ribosome and protect against the mistranslation of Phe codons as Tyr (11, 
12).    
The eubacterial, archaeal, and eukaryotic cytoplasmic PheRSs are heterotetrameric 
proteins composed of two α/β-heterodimers in which the α-subunits contain the active site and 
the β-subunits contain the editing site (13, 14). In eukaryotic cells separate translational systems 
are maintained in the cytoplasm and organelles, and aaRSs from both are encoded in the nucleus, 
with organelle forms synthesized as preproteins, which are then imported and processed (15). 
The mitochondrial form of PheRS (mtPheRS), as well as the chloroplast form, is an α-subunit 
monomer that lacks a recognizable editing domain, consistent with the absence of editing in 
some other mitochondrial aaRSs (16–18). Whereas ctPheRS and eubacterial PheRS possess a 
posttransfer editing activity against misacylated species, mtPheRS does not have the ability to 
edit mischarged Tyr- tRNAPhe, nor do mitochondria contain any trans-editing activity able to 
compensate for this deficiency (19). We now show that in Saccharomyces cerevisiae mtPheRS 
relies solely on a high level of specificity for Phe over Tyr for quality control of aminoacylation. 
A decrease in the amino acid specificity of PheRS blocked mitochondrial biogenesis but did not 
affect normal growth when tested in either the yeast cytoplasm or a bacterial model system. 
These data reveal strikingly different requirements for aaRS-mediated translation quality control 
in various cellular environments. 
 
Results 
Amino Acid Specificity of PheRS. Previous studies of Escherichia coli PheRS showed that the 
replacement αA294G enlarged the amino acid binding pocket of the active site of the enzyme, 
allowing tRNA aminoacylation with para-halogenated Phe analogs (20). Steady-state kinetic 
analyses confirmed the role of this residue in E. coli PheRS quality control, the αA294G variant 
showing almost a 100-fold loss in specificity for Phe over Tyr (Table 1). To investigate the 
conservation of this specificity determinant, 1,179 PheRS α-subunit sequences (877 from 
eubacteria, 23 from archaea, and 160 and 119 cytosolic and mitochondrial eukaryotic, 
respectively) were aligned with ClustalX (21), guided by the three-dimensional structure of 
Thermus thermophilus PheRS [Fig. 1A (22)], and refined manually. αAla294 was found 
conserved at the equivalent position in all sequences except for 48 cytoplasmic PheRSs from 33 
genera of eukaryotes that contained a Gly residue (Fig. 1B). This natural substitution of Ala by 
Gly showed no obvious phylogenetic distribution and was observed in all fungi (not in 
microsporidia), in the primitive eukaryote Trichoplax adhaerens, and also in some higher 
eukaryotes. The lack of conservation of the αAla294 specificity determinant among several 
PheRSs prompted us to compare the substrate specificity of the S. cerevisiae mitochondrial 
(αAla333) and Cytoplasmic (αGly458) PheRSs, the latter of which contain a natural Ala to Gly 
substitution. The ctPheRS was 5 times more efficient (as reflected in kcat⁄KM) than the mtPheRS 
Appendix 1                                                                                                                                     14 
with respect to Phe activation and 80 times more efficient with respect to Tyractivation (Table 
1). These differences in amino acid activation kinetics revealed that the specificity for Phe over 
Tyr is 15-fold higher for mtPheRS than it is for ctPheRS. To further investigate the ability of the 
αAla294 equivalent residues to confer specificity during Phe/Tyr discrimination in S. cerevisiae, 
mtPheRS was engineered through an A333G replacement whereas the converse change, G458A, 
was made in ctPheRS. MtPheRS A333G showed a 17-fold reduced specificity for Tyr in vitro 
compared to wildtype mtPheRS, whereas ctPheRS αG458A displayed a 20-fold increase 
compared to wild-type, confirming the critical role of this residue in quality control during amino 
acid activation (Table 1).  
 
Table 1. Steady-state kinetic constants for ATP-[32P]PPi exchange for cytosolic and mitochondrial wild-type and 
variant PheRS from S. cerevisiae and E. coli. 
 
 
 
Mitochondrial PheRS Specificity is Essential for Respiratory Function. MtPheRS A333G 
displayed comparable substrate specificity to wild-type ctPheRS but lacked the latter protein’s 
ability to edit Tyr- tRNAPhe, which provided a means to investigate the importance of specificity 
for translational quality control in vivo by replacing wild-type mtPheRS with the A333G variant. 
To exclude possible indirect effects of the A333G replacement resulting from changes in 
secondary structure, CD spectral analysis was performed. Wild-type and mutant mtPheRS 
proteins showed nearly identical far-UV CD spectra, suggesting A333G does not induce major 
changes in global secondary structure (Fig 1C).        
 To test the effect of changing amino acid specificity in vivo, a chromosomal A333G 
replacement in MSF1 (encoding mtPheRS) was constructed in a haploid yeast strain resulting in 
the msf1-1 allele, and this strain was then crossed to a haploid wild-type to ensure the presence of 
fully functional mitochondria with an intact genome. Dissection of the heterozygous diploid 
MSF1/msf1-1 strain on fermentative medium (glucose) resulted in growth of all spores in each 
tetrad and replica plating onto media requiring respiratory function (ethanol plus glycerol) 
resulted in a nogrowth phenotype that segregated 2:2. On fermentative media both the msf1-1 
and msf1Δ strains showed a reduced level of growth compared to MSF1 (Fig. 2A and B). 
However, on respiratory media neither the msf1-1 nor msf1Δ strain showed any growth (Fig 2B). 
To determine if the mitochondria are unable to respire from the onset or the ability to respire is 
lost with time, MSF1/msf1-1 was sporulated and dissected directly onto respiratory medium (Fig. 
Mitochondrial 
WT  5±0. 180±7. 35±0. 1155±16 5±0. 0.005±0.000 7300
A333G   17± 140±1 8±0. 660±5 12.5±0. 0.02±0.00 426
Cytosolic 
WT  3±0. 603±4 194±1 637±30 184±3 0.4±0. 485
G458A  233±2 464±3 0.2±0. 3000±120 0.6±0.2 0.0002±0.000 10000
E. coli 
WT  2±0. 199±2 110±4 2200±70 35± 0.016±0.00 6800
A294G   4.5±1. 185±1 45±1 320±8 185±2 0.6±0.0 75
KM (μM) kcat (s‐1)  kcat/KM(s‐1/μM‐1) KM (μM) kcat (s‐1) kcat/KM(s‐1/μM‐1)
Phe  Tyr Specificity
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2C). While msf1-1 spores were able to germinate, growth was quickly arrested. It is possible that 
the limited growth seen is a result of the presence of both wild-type and mutant mtPheRS in the 
mitochondria at the onset of germination. Thus, the mitochondria may be able to respire for a 
very short time with the mitochondrial genome becoming unstable as a result of protein turnover 
and the increase in population of mutant mtPheRS present.   
 To investigate the presence or absence of the mitochondrial genome, msf1-1 was crossed 
with a MSF1 rho0 strain that encodes a wild-type mtPheRS but is devoid of the mitochondrial 
genome. If the msf1-1 strain is limited in respiratory activity because of the mutant mtPheRS but 
retains an intact mitochondrial genome, crossing with a MSF1 rho0 strain would result in a 
diploid with fully functional mitochondria, imparting the ability to grow on media requiring 
respiration. When tetrads from MSF1/msf1-1 were dissected, the spores allowed to germinate for 
36 h, and then crossed with the MSF1 rho0 strain to monitor the loss of the mitochondrial 
genome, 84 out of 100 msf1-1 spores maintained their mitochondrial genome, whereas 16 of 100 
spores had lost their mitochondrial genome at the time of crossing. However, after germination, 
if msf1-1 was grown in an overnight liquid culture before crossing, the MSF1 rho0 strain was 
unable to complement msf1-1, indicating a complete loss of the mitochondrial genome from 
msf1-1. These results demonstrate that reducing the specificity of mtPheRS is sufficient to 
destabilize the mitochondrial genome, which is then lost over time. This result is in agreement 
with previous findings in yeast where mutations inactivating mitochondrial translation result in 
mitochondrial genome instability (23).  
 
PheRS Quality Control Mechanisms are not Essential in E. coli or S. cerevisiae Cytoplasm. Loss 
of amino acid specificity encoded by the MSF1 gene resulted in ablation of mitochondrial 
biogenesis in S. cerevisiae, prompting us to investigate the requirements for this quality control 
mechanism in other cell types. In order to provide a direct comparison to mitochondria, E. coli 
was chosen as a model system because it has previously been demonstrated that mtPheRS can 
efficiently aminoacylate E. coli tRNAPhe (24, 25). To determine if loss of specificity in PheRS 
has a similar impact on cellular physiology in mitochondria and bacteria, we attempted to 
complement the E. coli strain NP37, which encodes a temperature-sensitive PheRS variant (26). 
NP37 was transformed with plasmids expressing MSF1, msf1-1, FARS2 (encoding human 
mtPheRS), or fars2-1 (A308G) and the resulting transformants grown at permissive or restrictive 
temperature (Fig. 3A and B). Both yeast and human wild-type mtPheRS, and the corresponding 
compromised specificity mutants, rescued the growth phenotype at a restrictive temperature. To 
determine if growth at the restrictive temperature resulted from retention of E. coli PheRS 
editing activity at 42 °C, Tyr- tRNAPhe hydrolysis activity was measured in cell-free extracts 
(Fig. 3C). NP37/fars2-1 extracts displayed editing activity when prepared from cells grown at 30 
°C but not at 42 °C, confirming that E. coli NP37 lacks both PheRS editing and aminoacylation 
activities at the restrictive temperature.        
 To further compare requirements for quality control in different cellular compartments, 
the effect of ablating the Tyr- tRNAPhe editing activity of ctPheRS was investigated in vivo. The 
yeast ctPheRS variant βD243A, which lacks editing activity (19), was inserted into the low copy-
number centromeric plasmid pFL36, resulting in the plasmid pFL36-frs1-1, which was then used 
to transform the diploid strain YLR060W BY4743 (FRS1/frs1Δ). The resulting strains were 
sporulated, dissected onto yeast extract/peptone/dextrose (YPD), and replica plated onto G418 
and complete supplement media minus leucine (CSM-Leu). The 36 resulting complete tetrads all 
showed 2:2 segregation on G418 and showed growth on CSM-Leu, confirming the viability of 
the frs1Δ strain complemented with frs1-1 (Fig. 4A). Enzymatic Tyr- tRNAPhe hydrolysis activity 
was not observed in extracts prepared from frs2Δ pFL36-frs1-1 cells, indicating that ctPheRS 
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editing activity is absent in this strain (Fig. 4B). Taken together, these findings suggest that 
neither high amino acid specificity nor nearcognate amino acid editing by PheRS are required for 
E. coli or S. cerevisiae cytoplasmic growth under normal conditions. 
 
 
       
 
Fig. 2. Growth of S. cerevisiae msf1-1. (A) Streak plates showing 
growth of diploid and haploid strains on YPDA and ethanol plus 
glycerol medium. (B) Serial dilutions of strains obtained from 
dissection of MSF1/msf1-1 on YPDA; MSF1 msf1-1, and msf1Δ on 
YPDA and ethanol plus glycerol medium. Plates were incubated at 30 
°C for 3 days. (C) Dissection of tetrads from MSF1/ MSF1, 
MSF1/msf1Δ, and MSF1/msf1-1 strains on ethanol plus glycerol 
medium. Plates were incubated at 30 °C for 3 (MSF1/MSF1) or 4 
days (MSF1/msf1Δ and MSF1/msf1-1).
Fig. 1. Active site specificity of mitochondrial and cytosolic PheRS. (A) Structure 
of active site of the α-subunit of T. thermophilus PheRS in complex with 
phenylalanyl-adenylate (22). The optimal size of the Phe binding pocket is 
provided by residue Ala314 (residue A333 of S. cerevisiae mitochondrial 
PheRS). Motifs 1, 2, and 3 forming the active site of PheRS are colored in 
green, red, and blue, respectively. (B) Alignment summary of PheRS motif 
3. The secondary structure elements of motif 3 are indicated on the top 
of the alignment, and position Ala314 is indicated by the arrowhead. Residues 
displaying more than 85% identity or similarity are depicted on black or 
gray background, respectively. (C) Secondary structural analysis of mtPheRS. 
Circular dichroism was measured at 25 °C with 5 μM samples of S. cerevisiae 
wild-type mtPheRS or the A333G variant. 
 
Discussion 
Amino Acid Selectivity of aaRSs. Early studies on protein synthesis suggested overall error rates 
of around one misincorporated valine per 3,000 isoleucine codons translated (4). Upon the basis 
of this and other studies, it was proposed that aaRSs would generally need to achieve at least 
3,000-fold selectivity for cognate over near-cognate amino acids to avoid elevating the error rate 
of protein synthesis (27). Amino acid selectivity takes into account both aaRS specificity and the 
relative cellular concentrations of the corresponding cognate and near-cognate substrates. aaRSs 
which did not show an overall selectivity above 1 in 3,000 were predicted to require some form 
of proofreading to maintain sufficient accuracy during aa-tRNA synthesis, as borne out by the 
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discovery of numerous editing mechanisms (10, 28). Biochemical characterization of the yeast 
PheRSs is consistent with this model; ctPheRS, an editing enzyme, displays 480-fold specificity 
for Phe over Tyr, which corresponds to a selectivity ranging from 1 in 400–2,000 depending on 
growth conditions (29). MtPheRS, which does not edit, displays 7,300-fold specificity for Phe 
over Tyr, which corresponds to a selectivity of 11,700 upon the basis of mammalian 
mitochondrial amino acid pools (30). E. coli PheRS displays a comparable predicted selectivity 
of 1 in 14,400 for Phe under standard conditions (31) while also retaining a robust editing 
activity (Table 2). The three PheRSs characterized here are all predicted to be equally effective 
in providing a level of cognate amino acid selectivity consistent with protein synthesis error rates 
lower than 1 in 3,000; the significant divergence in exactly how each enzyme prevents Tyr- 
tRNAPhe synthesis may reflect adaptations to specific cellular conditions, which could place 
greatly different demands on the accuracy of translation. How amino acid pools vary under 
different conditions in diverse cellular environments, and how this changes the demands on aaRS 
quality control, remains to be determined.   
 
Table 2. Predicted selectivity of PheRS in different cells and compartments. 
 
 
Divergent Cellular Requirements for Quality Control During Translation. The mitochondrial 
form of PheRS does not contain the β domain responsible for posttransfer editing and relies 
instead on a high level of amino acid specificity to maintain the fidelity of aminoacylation. This 
reliance on specificity alone is similar to mtLeuRS and certain prolyl-tRNA synthetases, all of 
which are highly specific and do not require editing, in contrast to their respective counterparts in 
E. coli, which both display robust editing activities (17, 18, 32, 33). The detrimental effects on 
the cell of reducing specificity for Phe confirmed the reliance of mtPheRS function on accurate 
amino acid recognition. Introduction of the A333G mtPheRS variant reduced the selectivity for 
Phe over Tyr to ~700:1, below the quality control “threshold” of 3; 000:1, a level of accuracy 
that proved to be too low to sustain mitochondrial biogenesis. Several proteins of the respiratory 
chain complex are synthesized within mitochondria (34, 35), and posttranslational quality control 
is used extensively to prevent dysfunction of the organelle (36). Our data now indicate that aaRS 
specificity is also an indispensable component of the quality control machinery in mitochondria. 
 The need for a high level of substrate specificity in order for PheRS to function properly 
in translation was not observed in bacteria or the yeast cytoplasm. Despite a specificity for Phe 
over Tyr of only ~420:1, A333G mtPheRS was able to support growth of E. coli on complete 
media. βD243A ctPheRS has a similar specificity, cannot edit mischarged tRNAPhe, and also 
supports cytoplasmic protein synthesis and growth. This ability to tolerate low specificity is in 
sharp contrast to the requirement for high amino acid specificity in mitochondria and provides 
direct evidence that certain cell types differ with respect to their requirements for quality control 
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during translation. The notion that translation quality control requirements are cell-specific is 
supported by other recent in vivo studies using a mouse model. Lee et al. found that a missense 
mutation in the editing site of AlaRS resulted in the accumulation of misfolded proteins and cell 
death in terminally differentiated Purkinje neuronal cells. Only these nondividing cells, which 
contain an extremely high concentration of protein, show this phenotype while all other cells 
appear normal. When taken together with these findings, our data now clearly indicate that the 
requirements for quality control during translation vary greatly depending on cellular physiology. 
Given that both E. coli and the yeast cytoplasm can tolerate a low specificity for Phe over Tyr 
yet contain proofreading PheRSs, it is also apparent that the true role of aaRS editing in the cell 
still remains to be fully elucidated. 
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Materials and Methods 
Protein Preparation and Analysis. Proteins were prepared as described previously (12, 19). E. 
coli BL21-RIL/pET16b producing His6-tagged mtPheRS encoded by the MSF1 gene was a gift 
from R.A. Zimmermann (University of Massachusetts, Amherst, MA). The ctPheRS α and β 
subunits, encoded by the FRS2 and FRS1 genes, respectively, were expressed in tandem from 
pQE31- FRS-sc (producing His6-tagged WT ctPheRS) in E. coli BL21-RIL. E. coli pET- 21c(þ) 
encoding human mtPheRS (FARS2), producing mature His6-tagged wild-type PheRS, was a gift 
from L.L. Spremulli (University of North Carolina, Chapel Hill, NC). His6-tagged proteins were 
purified on nickel-nitrilotriacetic acid-agarose by standard procedures. Point mutations were 
introduced by site-directed mutagenesis using the Quikchange procedure (Stratagene). CD 
spectra were measured at 25 °C in an Aviv 62A DS spectropolarimeter (Aviv). The protein 
concentration was 5 μM in 50 mM Tris-HCl, pH 7.5, and 5% glycerol. CD spectra were 
measured from 200 to 250 nm (five scans per sample) with a step size of 1 nm in a 1 mm path 
length cuvette with 1 nm bandwidth and 5 sec averaging time. Protein-only spectra were 
obtained by subtracting the CD signal for buffer alone.       
 ATP-PPi exchange reactions were performed at 37 °C as described (19) with the 
exception that the amounts of amino acids used were 1.3 μM–1 mM Phe or 170 μM–6.8 mM 
Tyr, and the concentration of enzymes used was 5–150 nM ctPheRS, 150 nM mtPheRS, or 100 
nM E. coli PheRS. To ensure the absence of Phe contamination, Tyr was subjected to several 
cycles of heating and cooling to remove any trace amounts of Phe (37). Posttransfer editing 
reactions contained 100 mM Na-Hepes, pH 7.2, 30 mM KCl, 10 mM MgCl2, 2 μM  [14C] Tyr- 
tRNAPhe, and 74 μg (OD595) of E. coli crude extract or 0.006 U of S. cerevisiae extract, where 
one unit of PheRS corresponds to the amount of protein necessary to catalyze the formation of 1 
nmol of Phe- tRNAPhe min−1 at 37 °C. E. coli crude extracts were preincubated at 42 °C before 
addition to the reaction mixture. After the addition of crude extract, reaction mixtures were 
incubated at 37 or 42 °C, and the deacylation reaction followed bymeasuring the [14C] Tyr- 
tRNAPhe remaining in aliquots of 7 μL removed after 0–6 min of incubation.  
 
Construction, Manipulation, and Growth of Yeast Strains. Strains derived from S. cerevisiae 
W303 (MATa, ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1- 100) were used to carry out all 
in vivo experiments with the exception of those used in test crosses. In vivo site-directed 
mutagenesis was performed by the delitto perfetto method (38). A counter selectable reporter 
(CORE) cassette was inserted into the wild- type MSF1 gene of wild-type diploid S. cerevisiae 
near the A333 codon through homologous recombination resulting in the msf1::CORE strain. 
Upon introduction of the CORE cassette, cells were sporulated, resulting in 1:1 segregation of 
the cassette into the daughter spores. Haploid cells containing the msf1::CORE strain were rho0. 
Recombinant MSF1 with mutations created by quick-change site-directed mutagenesis was used 
to transform msf1::CORE rho0 haploid cells. Recombination of the mutated gene with the 
msf1::CORE led to excision of the CORE and insertion of the A333G mutation (msf1-1) into the 
chromosome. To recover mitochondria, the haploid W303 msf1-1 strain was mated to a W303 
wild-type haploid strain, resulting in a heterozygous rho+ strain. The resulting diploid strain was 
sporulated to obtain haploid msf1-1 cells. Insertion of the A333G mutation in W303 msf1-1 was 
confirmed by sequencing. Haploid strains are referred to as W303 MSF1 or W303 msf1-1 
depending on the genotype. W303 msf1Δ was created through the replacement of the MSF1 open 
reading frame with a KanMX4 cassette by homologous recombination in a W303 MSF1 
homozygous diploid. W303 msf1Δ was then obtained by sporulation and dissection.   
 The presence of mitochondrial DNA was determined by crossing W303 haploid strains 
with KL14-4A/60 (MATa, his1, trp2, rho0) or D27310B/50 (MATα, ade5, rho0) (39) on minimal 
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glycerol medium followed by replica plating onto minimal ethanol/glycerol medium. To 
determine the initial state of the mitochondria W303 diploid cells were grown in either yeast 
extract/peptone/ dextrose/adenine (YPDA), sporulated on minimal sporulation medium (1% 
CH3COOK, 0.1% yeast extract, 0.05% glucose), and dissected directly onto ethanol plus 
glycerol medium and grown for 3–4 days at 30 °C.        
 S. cerevisiae strain YLR060W BY4743 (MATa/MATα, his3Δ1/his3Δ1, leu2Δ0/ leu2Δ0, 
lys2Δ0/LYS2, MET15/met15Δ0, ura3Δ0/ura3Δ0, FRS1/frs1::kanMX4) (ATCC) was used to carry 
out all in vivo experiments on yeast cytosolic pheRS (FRS1). A 3-kb genomic region including 
FRS1 and its native regulators was cloned into the centromeric shuttle vector pFL36 and the 
D243A mutation (frs1-1) introduced through site-directed mutagenesis. YLR060W BY4743 was 
transformed with pFL36-FRS1, pFL36-frs1-1, or pFL36. Resulting strains were sporulated, 
dissected on YPD, and replica plated onto YPD with 200 μg⁄mL geneticin (G418) and complete 
supplement media minus leucine (CSM -Leu; Sunrise Science Products). Growth rates of haploid 
frsΔ strains complemented with pFL36-FRS1 and pFL36-frs1-1 were determined in duplicate in 
250-mL flasks with 50 mL of YPD. Cultures were shaken at 225 rpm at 30 °C. Samples of 1 mL 
were taken every hour with growth monitored spectrophotometrically at an absorbance of 660 
nm. Cell-free extracts were prepared the same as E. coli cell-free extracts with the exception the 
cells were grown in 100 mL YPD overnight, washed, and resuspended in 5 mL 100 mM Tris-
HCl, pH 8.0, 5 mM 2-mercaptoethanol, 500 μM diisopropyl fluorophosphate, 500 μM 
phenylmethylsulfonyl fluoride. Cells were opened with 1 mL glass beads by vortexing for 2 min, 
6 times.  
 
E. coli pheSts Complementation and Preparation of Cell-Free Extracts. E. coli NP37 (26) was 
transformed with the mature human mtPheRS (FARS2) cloned in pET-21c(þ) and pRARE, 
which expresses six rare tRNAs (Novagene). Point mutations were introduced by quick-change 
site-directed mutagenesis with the Quikchange kit (Stratagene). Transformants were plated on 
LB supplemented with 100 μg⁄mL ampicillin, 30 μg⁄mL chloramphenicol, 0.4 mM IPTG at 30 or 
42 °C for 48 h. Prior to preparation of cell-free extracts, revertants of NP37 were removed from 
plates grown at 42 °C for 48 h. The remaining cells were then removed from the plates and 
resuspended in 100 mM Tris-HCl, pH 8.0, 5 mM 2-mercaptoethanol, 500 μM diisopropyl 
fluorophosphate, 500 μM phenylmethylsulfonyl fluoride, washed once, and resuspended in the 
same buffer. Cells were sonicated at 70% output with a Sonifier 450 (Branson) equipped with a 
microprobe. The resulting extract was centrifuged at 100; 000 × g for 1 h. The soluble extracts 
were dialyzed overnight at 4 °C against 100 mM Tris-HCl, pH 8.0, 5 mM 2-mercaptoethanol, 1 
mM ethylenediaminetetraacetic acid and concentrated in the same buffer plus 50% glycerol. 
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